Major oil companies posted stronger-than-expected earnings despite production disruptions from Middle East conflicts and global energy system stress.
A planned takeover of Ovo Energy could create Britain's largest energy supplier, with officials assuring customers that existing tariffs will remain intact.
Thrive Capital, led by Joshua Kushner, has invested $100 million in e-commerce platform Shopify.
Multiple central banks and financial institutions issued guidance on monetary policy and market conditions amid ongoing economic uncertainty.
Several large-scale projects including UK's HS2 rail line and utility mergers are experiencing significant budget increases and timeline adjustments.
Chris Hohn's TCI hedge fund has significantly reduced its Microsoft position, reportedly cutting an $8 billion stake over concerns about AI market disruption.
Corporate earnings reports produced divergent stock reactions, with NXP Semiconductors surging while Microsoft faced challenges and cannabis stocks declined.
Texas metropolitan areas are attracting corporate relocations and experiencing significant population growth, with some cities leading national growth rates.
SpaceX has reportedly engaged 21 banks for a potential initial public offering under the internal code name 'Project Apex,' according to multiple reports.
Importers are starting to request refunds from a $166 billion pool of tariffs invalidated by the Supreme Court, though distribution may take weeks.
The International Monetary Fund reduced its UK growth projection to 0.8% this year, marking the largest downgrade among G7 nations.
Two major apartment REITs are reportedly close to combining in what would create a multifamily real estate giant.
Harvard University faculty voted to cap the number of top grades that can be awarded in approximately 20% of undergraduate courses.
U.S. stock markets gained ground amid reports suggesting possible progress toward resolving tensions with Iran.
Chinese biotech firm Innovent Biologics signed a major cancer drug development deal with Pfizer worth up to $10.5 billion.
Page 15 of 100 (1498 stories)